|
免疫干预实验性自身免疫性重症肌无力小鼠的B细胞活化机制 |
|
免疫干预实验性自身免疫性重症肌无力小鼠的B细胞活化机制 |
|
|
[Abstract] AIM: To explore the therapic effect of Tα146162 iMDCs in C57BL/6 mice with experimental autoimmune myasthenia graves(EAMG), and illustrate whether this therapic effect is related with the change of B cells activation. METHODS: Adult male C57BL/6 mice were randomly divided into EAMG groups(A), the prevention group(B) and control group(C); Immature bone marrow dendritic cells were cultured and pulsed with Tα146162. Mice of A group and B group were evaluated for clinical score till the day they were put to death. The expression and phosphorylation of Syk, Lyn, Btk and PLCγ2 protein were measured by Western blot. RESULTS: 75% mice of A group and 25% mice of B group were developed the accumulated incidence, the difference was significant (P<0.05). The average clinical score of A group and B group were 1.69±1.12 vs 0.35±0.67(P<0.01) at the termination of experiment. The expression 上一页 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] ... 下一页 >> |
|
|
|
上一个论文: 人大肠癌抗原基因 cDNA噬菌体表达文库的构建和鉴定 下一个论文: 酪氨酸激酶抑制剂A77 1726阻断IL13对成纤维细胞的促胶原合成作用 |
|